文献速递术前评估与围术期医学气道管理

舒更葡糖逆转神经肌肉阻滞与日间手术术后留观时长的关联:多中心医院登记研究

Association of sugammadex reversal of neuromuscular block and postoperative length of stay in the ambulatory care facility: a multicentre hospital registry study.
PubMed 文献 · Br J Anaesth · 2022-12-17

舒更葡糖组术后留观时长短9.5分钟(95%CI -10.5至-8.5),直接住院费用低77美元(95%CI -88至-66),术后恶心呕吐发生率更低(17.2% vs 19.6%),且在高龄高危短手术患者中效应更明显。

要点

  • 舒更葡糖逆转较新斯的明缩短日间手术术后留观时长约9.5分钟,降低直接费用约77美元。
  • 效应在高龄、ASA>2、手术<2小时患者中放大,留观时长缩短18.2分钟。
  • 舒更葡糖组术后恶心呕吐发生率更低(17.2% vs 19.6%),并介导留观时长缩短。

核心结论

  • 与新斯的明相比,舒更葡糖逆转神经肌肉阻滞与日间手术术后留观时长小幅缩短相关,在高龄高危患者中效应更明显,并可由术后恶心呕吐减少解释。

主要发现

  • 舒更葡糖组较新斯的明组术后留观时长调整差异为-9.5分钟(95%CI -10.5至-8.5),直接住院费用调整差异为-77美元(95%CI -88至-66),P<0.001。
  • 年龄>65岁、ASA分级>2、手术时间<2小时的患者中,留观时长调整差异为-18.2分钟(95%CI -23.8至-12.4),直接费用调整差异为-176美元(95%CI -220至-128),P<0.001。
  • 舒更葡糖组术后恶心呕吐发生率为17.2%,新斯的明组为19.6%(P<0.001),且术后恶心呕吐介导了留观时长缩短的效应。

临床怎么用

  • 日间手术全麻使用神经肌肉阻滞时,可优先考虑舒更葡糖逆转以缩短术后留观时间并降低费用。
  • 对高龄、高ASA分级、短手术患者,舒更葡糖逆转的留观时长和费用获益更明显。
  • 舒更葡糖可能通过减少术后恶心呕吐来缩短留观时长。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Encapsulation of rocuronium or vecuronium with sugammadex can reverse neuromuscular block faster than neostigmine reversal. This pharmacodynamic profile might facilitate patient discharge after ambulatory surgery. METHODS: We included patients who underwent ambulatory surgery with general anaesthesia and neuromuscular block between 2016 and 2021 from hospital registries at two large academic healthcare networks in the USA. The primary outcome was postoperative length of stay in the ambulatory care facility (PLOS-ACF). We examined post hoc whether the type of reversal affects postoperative nausea and vomiting and direct hospital costs. RESULTS: Among the 29 316 patients included, 8945 (30.5%) received sugammadex and 20 371 (69.5%) received neostigmine for reversal. PLOS-ACF and costs were lower in patients who received sugammadex vs neostigmine (adjusted difference in PLOS-ACF: -9.5 min; 95% confidence interval [95% CI], -10.5 to -8.5 min; adjusted difference in direct hospital costs: -US$77; 95% CI, -$88 to -$66; respectively; P<0.001). The association was magnified in patients over age 65 yr, with ASA physical status >2 undergoing short procedures (<2 h) (adjusted difference in PLOS-ACF: -18.2 min; 95% CI, -23.8 to -12.4 min; adjusted difference in direct hospital costs: -$176; 95% CI, -$220 to -$128; P<0.001). Sugammadex use was associated with reduced postoperative nausea and vomiting (17.2% vs 19.6%, P<0.001), which mediated its effects on length of stay. CONCLUSIONS: Reversal with sugammadex compared with neostigmine was associated with a small decrease in postoperative length of stay in the ambulatory care unit. The effect was magnified in older and high-risk patients, and can be explained by reduced postoperative nausea and vomiting. Sugammadex reversal in ambulatory surgery may also help reduce cost of care.

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Azimaraghi O, Ahrens E, Wongtangman K, et al. Association of sugammadex reversal of neuromuscular block and postoperative length of stay in the ambulatory care facility: a multicentre hospital registry study. Br J Anaesth. 2022. PMID: 36535827. doi:10.1016/j.bja.2022.10.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。